Learn More
Medchemexpress LLC 3-[4-(6-(3-(dimethylamino)propoxy)benzo[d]oxazol-2-yl)phenoxy]-N,N-dimethylpropan-1-amine | 1219962-49-8 | 98.8% | 397.519 g·mol⁻¹ | C23H31N3O3 | 25MG

Supplier: Medchemexpress LLC HY12460325MG
AT791 is a small-molecule, orally bioavailable inhibitor of Toll-like receptors TLR7 and TLR9. It blocks DNA-TLR9 interaction in vitro and suppresses cytokine responses such as IL-6 and type I interferon in human and mouse cells, making it suitable for immunology and autoimmune research.
- Orally bioavailable small-molecule inhibitor of TLR7 and TLR9.
- Blocks DNA-TLR9 interaction and inhibits TLR-mediated signaling in vitro.
- Potent activity against TLR9 (low-nanomolar IC50) and weaker activity against TLR7.
- High-purity solid with good solubility in DMSO (~10 mM) for assay preparation.
- Appropriate for cellular and in vivo studies of TLR-driven immune responses.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.